RIPK1 and Alzheimer disease: To determine whether necroptosis was inactivated in AD mice with NAD+ augmentation, we found that NMN indeed inhibited necroptosis, as evidenced by an apparent reduction in RIPK1, RIPK3, and MLKL expressions by immunoblotting analysis (Supplementary Fig. 3k, l).